Key Account Manager Biosimilars - East of France at IQVIA

Lyon, Auvergne-Rhône-Alpes, France

IQVIA Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

  • Pharmaceutical sales experience, especially with high-cost drug pharmacists within hospitals
  • Experience in biosimilars or therapy areas such as Rare Disease, Haematology, Nephrology, Immunology, Oncology, Endocrinology, Orthopaedics, or Rheumatology
  • Life Sciences degree or equivalent; advanced degrees in Business Administration or Health Economics are a plus
  • Strong relationship-building skills with both external and internal customers
  • Fluent in French and English
  • Willingness to travel regularly throughout the territory
  • Full driving license essential
  • Pharmaceutical sales representative Diploma

Responsibilities

  • Manage commercial activities and engage with hospital stakeholders to promote biosimilar products
  • Collaborate with colleagues to provide decision-makers with the necessary information for optimal adoption and prescribing
  • Establish our client as a trusted partner in the biosimilars/biologics market
  • Collect and report relevant data
  • Achieve sales and market share growth

Skills

Pharmaceutical Sales
Biosimilars
Hospital Pharmacists
Stakeholder Engagement
French
English
Relationship Building
Sales Reporting
Market Access
Therapy Areas

IQVIA

Advanced analytics and clinical research services

About IQVIA

IQVIA provides advanced analytics, technology solutions, and clinical research services specifically for the life sciences industry. Their services utilize extensive data resources and technology to create connections within healthcare, allowing clients to gain insights that help speed up the development and marketing of new medical treatments. This process is facilitated by their IQVIA Connected Intelligence™ system, which offers quick and flexible insights. IQVIA stands out from competitors by focusing on patient privacy, employing various technologies to protect individual data. The company's goal is to enhance healthcare outcomes by supporting biotech, pharmaceutical, and medical device companies, as well as researchers and government agencies, in understanding diseases and advancing medical science.

Durham, North CarolinaHeadquarters
1998Year Founded
$3,526MTotal Funding
POST_IPO_EQUITYCompany Stage
Cybersecurity, Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Rapid advancement of cancer vaccines may disrupt traditional clinical research models.
Proliferation of disparate technological solutions causes technology overload in clinical trials.
Generative AI technologies face challenges in adoption due to data privacy concerns.

Differentiation

IQVIA leverages advanced analytics and big data for life sciences solutions.
The company offers privacy-enhancing technologies to protect individual patient data.
IQVIA's AI Assistant provides rapid, actionable insights for healthcare and life sciences.

Upsides

Increased adoption of decentralized clinical trials enhances patient-centric study designs.
AI-driven drug discovery accelerates identification of potential drug candidates.
Expansion of telemedicine facilitates remote patient monitoring and data collection.

Land your dream remote job 3x faster with AI